Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
OMRON ( (JP:6645) ) has provided an update.
Omron Healthcare, a Kyoto-based subsidiary of Omron Corporation specializing in home-use and medical health devices, health-management software and related services, is expanding its footprint in the healthcare technology space. The company leverages its product portfolio to strengthen its position in connected health and medical monitoring solutions.
The board of Omron Healthcare has approved the commencement of a tender offer to acquire shares and share options of Matsuya R&D Co., Ltd., listed on the Tokyo Stock Exchange Growth Market. Following completion of required competition-law approvals in Taiwan and Vietnam, including clearance from the Taiwan Fair Trade Commission, the tender offer is set to begin, marking a strategic move that could enhance Omron Healthcare’s capabilities and market reach in healthcare-related technologies.
The most recent analyst rating on (JP:6645) stock is a Buy with a Yen6500.00 price target. To see the full list of analyst forecasts on OMRON stock, see the JP:6645 Stock Forecast page.
More about OMRON
Omron Healthcare Co., Ltd., a subsidiary of Omron Corporation, develops and sells home-use and medical health devices alongside health-management software and health-promotion services, positioning the company in the consumer and professional healthcare equipment market. Based in Muko-shi, Kyoto, it serves both domestic and international markets with digital health solutions aimed at preventive care and medical monitoring.
YTD Price Performance: 45.63%
Average Trading Volume: 1,634,437
Technical Sentiment Signal: Buy
Current Market Cap: Yen1121.9B
Find detailed analytics on 6645 stock on TipRanks’ Stock Analysis page.